171 related articles for article (PubMed ID: 37373014)
21. Upregulation of CYP2S1 by oxaliplatin is associated with p53 status in colorectal cancer cell lines.
Yang C; Zhou Q; Li M; Tong X; Sun J; Qing Y; Sun L; Yang X; Hu X; Jiang J; Yan X; He L; Wan C
Sci Rep; 2016 Sep; 6():33078. PubMed ID: 27609465
[TBL] [Abstract][Full Text] [Related]
22. Characterization of p53 wild-type and null isogenic colorectal cancer cell lines resistant to 5-fluorouracil, oxaliplatin, and irinotecan.
Boyer J; McLean EG; Aroori S; Wilson P; McCulla A; Carey PD; Longley DB; Johnston PG
Clin Cancer Res; 2004 Mar; 10(6):2158-67. PubMed ID: 15041737
[TBL] [Abstract][Full Text] [Related]
23. The effects of a novel aliphatic-chain hydroxamate derivative WMJ-S-001 in HCT116 colorectal cancer cell death.
Huang YH; Huang SW; Hsu YF; Ou G; Huang WJ; Hsu MJ
Sci Rep; 2015 Oct; 5():15900. PubMed ID: 26510776
[TBL] [Abstract][Full Text] [Related]
24. Proton induces apoptosis of hypoxic tumor cells by the p53-dependent and p38/JNK MAPK signaling pathways.
Lee KB; Kim KR; Huh TL; Lee YM
Int J Oncol; 2008 Dec; 33(6):1247-56. PubMed ID: 19020758
[TBL] [Abstract][Full Text] [Related]
25. p53 dependent LGR5 inhibition and caspase 3 activation are critically involved in apoptotic effect of compound K and its combination therapy potential in HCT116 cells.
Pak JN; Jung JH; Park JE; Hwang J; Lee HJ; Shim BS; Kim SH
Phytother Res; 2020 Oct; 34(10):2745-2755. PubMed ID: 32403193
[TBL] [Abstract][Full Text] [Related]
26. Proteomic Analysis of miR-195 and miR-497 Replacement Reveals Potential Candidates that Increase Sensitivity to Oxaliplatin in MSI/P53wt Colorectal Cancer Cells.
Poel D; Boyd LNC; Beekhof R; Schelfhorst T; Pham TV; Piersma SR; Knol JC; Jimenez CR; Verheul HMW; Buffart TE
Cells; 2019 Sep; 8(9):. PubMed ID: 31546954
[TBL] [Abstract][Full Text] [Related]
27. Comparison of oxaliplatin- and curcumin-mediated antiproliferative effects in colorectal cell lines.
Howells LM; Mitra A; Manson MM
Int J Cancer; 2007 Jul; 121(1):175-83. PubMed ID: 17330230
[TBL] [Abstract][Full Text] [Related]
28. β-Sitosterol Reverses Multidrug Resistance via BCRP Suppression by Inhibiting the p53-MDM2 Interaction in Colorectal Cancer.
Wang Z; Zhan Y; Xu J; Wang Y; Sun M; Chen J; Liang T; Wu L; Xu K
J Agric Food Chem; 2020 Mar; 68(12):3850-3858. PubMed ID: 32167760
[TBL] [Abstract][Full Text] [Related]
29. [Synergistic effect of polysaccharide from
Li P; Yuan P; Que Y; Liu X; Wang G
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Apr; 41(4):504-513. PubMed ID: 33963708
[TBL] [Abstract][Full Text] [Related]
30. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice.
Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X
Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338
[TBL] [Abstract][Full Text] [Related]
31. Oxaliplatin-induced gamma-H2AX activation via both p53-dependent and -independent pathways but is not associated with cell cycle arrest in human colorectal cancer cells.
Chiu SJ; Lee YJ; Hsu TS; Chen WS
Chem Biol Interact; 2009 Dec; 182(2-3):173-82. PubMed ID: 19735649
[TBL] [Abstract][Full Text] [Related]
32. The glutamate transport inhibitor DL-Threo-β-Benzyloxyaspartic acid (DL-TBOA) differentially affects SN38- and oxaliplatin-induced death of drug-resistant colorectal cancer cells.
Pedraz-Cuesta E; Christensen S; Jensen AA; Jensen NF; Bunch L; Romer MU; Brünner N; Stenvang J; Pedersen SF
BMC Cancer; 2015 May; 15():411. PubMed ID: 25981639
[TBL] [Abstract][Full Text] [Related]
33. Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect.
Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
Mol Cancer Ther; 2004 Feb; 3(2):169-78. PubMed ID: 14985457
[TBL] [Abstract][Full Text] [Related]
34. Serum Starvation Sensitizes Anticancer Effect of
Ji KY; Kim KM; Kim YH; Shim KS; Lee JY; Kim T; Chae S
Am J Chin Med; 2021; 49(4):1001-1016. PubMed ID: 33827386
[TBL] [Abstract][Full Text] [Related]
35. The role of spermidine/spermine N1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells.
Allen WL; McLean EG; Boyer J; McCulla A; Wilson PM; Coyle V; Longley DB; Casero RA; Johnston PG
Mol Cancer Ther; 2007 Jan; 6(1):128-37. PubMed ID: 17237273
[TBL] [Abstract][Full Text] [Related]
36. Heparin regulates colon cancer cell growth through p38 mitogen-activated protein kinase signalling.
Chatzinikolaou G; Nikitovic D; Berdiaki A; Zafiropoulos A; Katonis P; Karamanos NK; Tzanakakis GN
Cell Prolif; 2010 Feb; 43(1):9-18. PubMed ID: 19845689
[TBL] [Abstract][Full Text] [Related]
37. Helveticoside Exhibited p53-dependent Anticancer Activity Against Colorectal Cancer.
An N; Sun Y; Ma L; Shi S; Zheng X; Feng W; Shan Z; Han Y; Zhao L; Wu H
Arch Med Res; 2020 Apr; 51(3):224-232. PubMed ID: 32147288
[TBL] [Abstract][Full Text] [Related]
38. Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK.
Bu HQ; Liu DL; Wei WT; Chen L; Huang H; Li Y; Cui JH
Oncol Rep; 2014 Feb; 31(2):975-82. PubMed ID: 24297112
[TBL] [Abstract][Full Text] [Related]
39. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
Park SH; Seong MA; Lee HY
Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187
[TBL] [Abstract][Full Text] [Related]
40. Role of p21waf1/cip1 in effects of oxaliplatin in colorectal cancer cells.
Hata T; Yamamoto H; Ngan CY; Koi M; Takagi A; Damdinsuren B; Yasui M; Fujie Y; Matsuzaki T; Hemmi H; Xu X; Kitani K; Seki Y; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
Mol Cancer Ther; 2005 Oct; 4(10):1585-94. PubMed ID: 16227409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
